Literature DB >> 25410306

Classification models of HCV NS3 protease inhibitors based on support vector machine (SVM).

Maolin Wang, Shouyi Xuan, Aixia Yan, Changyuan Yu1.   

Abstract

Inhibition of the hepatitis C virus (HCV) non-structural protein 3 (NS3) serine protease by molecule inhibitors is an attractive strategy for the treatment of hepatitis C. We built four classification models based on a dataset of 413 HCV NS3 protease inhibitors using support vector machine method. The best performing model obtains the best prediction performance for the test set with prediction accuracy, sensitivity (SE), specificity (SP) and Matthews correlation coefficient (MCC) of 90.76%, 92.21%, 88.10% and 0.799, respectively. The number of rotatable bonds (NRotBond), charge and electronegativity related properties were found to be correlated with the bioactivity of the inhibitors. The ECFP_4 analyses of structural features were performed and it was found that the cyclopropyl with acylsulfonamide group was the unique substructure in the active inhibitors. The method with dataset split by Kohonen's self-organizing map and descriptors selected by SVMAttributeEval presented in this study can be employed in virtual screening for discovering novel inhibitors of HCV NS3 protease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25410306     DOI: 10.2174/1386207317666141120122554

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  2 in total

1.  Targeting non-structural proteins of Hepatitis C virus for predicting repurposed drugs using QSAR and machine learning approaches.

Authors:  Sakshi Kamboj; Akanksha Rajput; Amber Rastogi; Anamika Thakur; Manoj Kumar
Journal:  Comput Struct Biotechnol J       Date:  2022-06-30       Impact factor: 6.155

2.  Clinical utility of brain-derived neurotrophic factor as a biomarker with left ventricular echocardiographic indices for potential diagnosis of coronary artery disease.

Authors:  K G Monisha; Paramasivam Prabu; M Chokkalingam; Ram Murugesan; Dragan Milenkovic; Shiek S S J Ahmed
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.